NCT00733785View on ClinicalTrials.gov

PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 13, 2008

Primary Completion Date

November 28, 2008

Study Completion Date

November 28, 2008

Conditions
Alzheimer's Disease
Interventions
DRUG

Rosiglitazone XR

Rosiglitazone extended release formulation

Trial Locations (1)

14050

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY